About This Role This person is a hands-on leader with responsibility for advancing the execution of significant elements of program strategy and cross-functional execution for the Dravet (Zorevunersen) program. Strong performance in this role enables the Zorevunersen PDC
About This Role: As the International Commercial Lead for Alzheimer’s Disease, you will drive performance, strategic direction, and commercialization excellence across diverse international markets. This pivotal role involves ensuring strong alliance governance, effective cross-regional alignment, and
Position Summary: The EU CTR Submission Lead is responsible for leading and overseeing the full lifecycle of regulatory submissions for clinical trials conducted under the EU Clinical Trial Regulation (EU CTR 536/2014) via the Clinical Trials
About This Role The PO&T Commercial Asset Development Leader is a member of the Asset Development & Portfolio Management (ADPM) team which provides cross-functional guidance across PO&T’s line functions for commercial assets. The role oversees and
About This Role The Senior Director, Alzheimer’s Global Diagnostics & Disease Area Strategy, will lead the overall global AD diagnostic pathway strategy and disease area strategy for the Alzheimer’s Disease and Dementia Franchise. Significant collaboration is
Job Scope: What is this job’s focus? The Associate Director, EU CTR Strategy & Operations Excellence supports the Head of EU CTR in providing leadership and strategic oversight for the implementation, optimization, and continuous improvement of all
About This Role: The Global Launch and Commercial Operations Lead is a senior individual contributor accountable for the end‑to‑end governance, readiness, and execution excellence of Biogen’s global commercial launch of zorevunersen — a potential first-in-class disease-modifying
About This Role The Senior Medical Director, Global Medical Affairs, Nephrology will be a strategic partner providing expert medical leadership to guide medical strategy development, launch planning, and support for our Glomerular Nephritis programs, including IgAN and Primary
About This Role: As the Senior Launch Lead, you will be a pivotal figure in orchestrating global supply execution for complex product launches and major lifecycle events across multiple markets. This role is embedded within the
Business Introduction At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines,
A leading cancer therapy company, located in Zug, Switzerland, is seeking a Senior Medical Director to lead clinical programs in Tumor Treating Fields therapy. In this role, you will collaborate with a multidisciplinary oncology team, author critical
At Novocure, every role contributes to extending the lives of people living with cancer. As our new Senior Director, Clinical Regulatory Affairs, you’ll play a key part in this mission. This is a highly visible global
What its about Partners Group is searching for a Lead Product Manager to join our Product Management team in Zug, Switzerland. The Product Management team takes full ownership of steering and executing key initiatives across the
At Novocure, every role contributes to extending the lives of people living with cancer. As our new Senior Medical Director / Medical Director, Clinical Development, you’ll play a key part in this mission. As a key
About This Role As the Associate Director of International Auditing, you will spearhead the planning, execution, and oversight of Quality audits across manufacturing sites, affiliates, contract manufacturers, suppliers, and service providers throughout Europe and the Rest
About This RoleThe PO&T Commercial Asset Development Leader is a member of the Asset Development & Portfolio Management (ADPM) team which provides cross‑functional guidance across PO&T’s line functions for commercial assets. The role oversees and owns
Acadia Pharmaceuticals is a company dedicated to innovation in neurological and rare disease therapies. Our portfolio includes the first FDA‑approved treatments for Parkinson’s disease psychosis and Rett syndrome, and we are developing additional programs in Alzheimer’s disease